Nutricircle Limited has submitted its quarterly compliance certificate to BSE Limited, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018 for the quarter and year ended March 31, 2026.

Regulatory Compliance Filing

The company filed the mandatory certificate on April 6, 2026, through Managing Director Hitesh Mohanlal Patel (DIN: 02080625). The submission was addressed to BSE Limited's General Manager, Listing Department, referencing the company's scrip code 530219.

Certificate Confirmation

Bigshare Services Private Limited, serving as the company's Registrar and Share Transfer Agent, issued the compliance certificate dated April 4, 2026. The certificate specifically confirms that no dematerialization requests for equity shares were received during the period from January 1, 2026 to March 31, 2026.

The certification references multiple regulatory circulars:

• NSDL/CIR/II/5/2019 dated January 25, 2019
• CDSL/OPS/RTA/POLICY/2019/14 dated January 25, 2019
• SEBI letter ref no. MRD/DOP2/DSA2/OW/2019/2498/1 dated January 24, 2019

Company Information

Nutricircle Limited, formerly known as Shreeyash Industries Limited, operates from its registered office in Hyderabad, Telangana. The company maintains its corporate identification number as L18100TG1993PLC015901.

Regulatory Distribution

The compliance certificate was distributed to key regulatory bodies as required. Copies were forwarded to National Securities Depository Limited at their Mumbai office in Trade World, Kamala Mills Compound, and to Central Depository Services (India) Ltd. at Marathon Futurex, Lower Parel, Mumbai.

This quarterly filing demonstrates the company's adherence to SEBI's regulatory framework governing depositories and participants, ensuring transparency in share transfer and dematerialization processes.

Nutricircle Limited has announced a strategic research partnership with the Central Food Technological Research Institute (CSIR-CFTRI) through a Sponsored Project Agreement signed on April 2, 2026. The collaboration aims to develop fermented chickpea ingredients with enhanced protein bioavailability and improved techno-functional properties, representing a significant step in the company's research and development initiatives.

Project Overview and Objectives

The agreement establishes a comprehensive research framework for developing advanced chickpea-based ingredients through fermentation technology. CSIR-CFTRI will utilize its specialized expertise in microbiology and fermentation to create ingredients with superior nutritional profiles and functional characteristics.

Three-Phase Development Approach

The research project follows a structured three-phase methodology designed to optimize the fermentation process and ingredient characteristics:

Phase I - Strain Screening: This initial phase involves selecting superior microbial strains based on their proteolytic activity, probiotic potential, and ability to degrade anti-nutritional factors including phytic acid and RFOs (Raffinose Family Oligosaccharides).

Phase II - Process Optimization: The second phase focuses on establishing key fermentation parameters to achieve maximal anti-nutritional factor reduction and soluble protein/peptide release.

Phase III - Comprehensive Characterization: The final phase involves detailed assessment of the optimized ingredient, including determining enhanced In Vitro Protein Digestibility (IVPD), analyzing the proteolysis profile through SDS-PAGE, and measuring improved techno-functional properties such as emulsifying and foaming stability, along with desirable sensory characteristics.

Financial Structure and Payment Terms

The total project value amounts to Rs. 39,51,525, structured with sponsorship charges and applicable taxes:

The payment is divided into two installments:

Agreement Terms and Responsibilities

CSIR-CFTRI commits to completing the research activity and submitting the final report within six months of agreement signing and receipt of project charges. The institute will provide interim reports throughout the project duration and deliver a comprehensive final report upon completion.

The agreement includes strict confidentiality provisions requiring both parties to treat all exchanged information and generated data as confidential during the agreement tenure and for three years thereafter. Additionally, Nutricircle Limited will cover travel charges, TA/DA, and provide boarding, lodging, and local transport for CSIR-CFTRI personnel deputed outside their workplace in connection with the project.

Strategic Implications

This collaboration represents Nutricircle Limited's commitment to advancing nutritional science and developing innovative food ingredients. The partnership leverages CSIR-CFTRI's established research capabilities in food technology while supporting the company's product development objectives in the functional foods sector. The agreement allows for potential extensions through mutual consent and includes provisions for modification through written amendments by both parties.